검색
Teva Pharmaceutical Industries Ltd
TEVA관심 목록에 추가
39.810USD
-0.250-0.62%
시장 운영 시간 09/22, 11:21（ET）
46.38B시가총액
32.33P/E TTM
{index_name} 정보 Teva Pharmaceutical Industries Ltd 회사
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Teva Pharmaceutical Industries Ltd 프로필
종목 코드 TEVA
회사 이름Teva Pharmaceutical Industries Ltd
상장일Feb 06, 2087
CEOFrancis (Richard D)
직원 수33892
유형Depository Receipt
회계 연도 종료Feb 06
주소124 Dvora Hanevi'a St.
도시TEL AVIV-YAFO
증권 거래소NASDAQ OMX NASDAQ Basic NYSE
국가Israel
우편 번호6944020
전화97239148213
웹사이트https://www.tevapharm.com/
종목 코드 TEVA
상장일Feb 06, 2087
CEOFrancis (Richard D)
Teva Pharmaceutical Industries Ltd의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
2.12M
+0.68%
Mr. Richard D. Francis
Mr. Richard D. Francis
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.18M
+0.59%
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
885.93K
+11.77%
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
448.01K
+4.85%
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
183.56K
-16.34%
Dr. Eric A. Hughes
Dr. Eric A. Hughes
Executive Vice President - Global R&D, Chief Medical Officer
Executive Vice President - Global R&D, Chief Medical Officer
134.88K
+20.14%
Mr. Gerald M. (Jerry) Lieberman
Mr. Gerald M. (Jerry) Lieberman
Independent Director
Independent Director
130.15K
+11.13%
Mr. Evan Lippman
Mr. Evan Lippman
Executive Vice President - Business Development
Executive Vice President - Business Development
130.04K
+33.98%
Ms. Rosemary A. (Rose) Crane
Ms. Rosemary A. (Rose) Crane
Independent Director
Independent Director
127.74K
+11.35%
Dr. Perry D. Nisen, M.D., Ph.D.
Dr. Perry D. Nisen, M.D., Ph.D.
Independent Director
Independent Director
119.81K
+12.10%
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Amir Elstein
Mr. Amir Elstein
Independent Director
Independent Director
2.12M
+0.68%
Mr. Richard D. Francis
Mr. Richard D. Francis
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.18M
+0.59%
Mr. Mark Sabag
Mr. Mark Sabag
Executive Vice President - International Markets Commercial
Executive Vice President - International Markets Commercial
885.93K
+11.77%
Dr. Sol J. Barer, Ph.D.
Dr. Sol J. Barer, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
448.01K
+4.85%
Mr. Richard Daniell
Mr. Richard Daniell
Executive Vice President - European Commercial
Executive Vice President - European Commercial
183.56K
-16.34%
Dr. Eric A. Hughes
Dr. Eric A. Hughes
Executive Vice President - Global R&D, Chief Medical Officer
Executive Vice President - Global R&D, Chief Medical Officer
134.88K
+20.14%
자주 묻는 질문
Teva Pharmaceutical Industries Ltd의 상위 5대 주주는 누구인가요?
Teva Pharmaceutical Industries Ltd의 상위 5대 주주는 다음과 같습니다: Mr. Amir Elstein
Teva Pharmaceutical Industries Ltd(TEVA)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, Teva Pharmaceutical Industries Ltd의 주식을 보유한 기관은 총 1226곳이며, 이들이 보유한 주식의 총 가치는 약 725.07M로 전체 발행 주식의 62.27%를 차지합니다. 이는 2025Q4 대비 9191465.00 증가한 수치입니다.
Teva Pharmaceutical Industries Ltd의 최대 수익원은 무엇인가요?
2026Q1 기준, Teva Pharmaceutical Industries Ltd의 Generic products 부문이 가장 높은 매출을 기록했으며, 금액은 2.10B로 전체 매출의 50.77%를 차지했습니다.